CIK 0001671584 · Non-accelerated filer<br>Smaller reporting company
Aptevo Therapeutics Inc.
Sign in to watch- Ticker
- APVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811567056
- Phone
- 206-838-0500
- Business address
- 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy SVP Operations, CMO bought 25,000 shares at $0.76 ($19,000)
- 4 Open-market buy Director bought 100,000 shares at $0.76 ($75,520)
- 4 Open-market buy Board of Directors bought 55,015 shares at $0.83 ($45,861)
- 4 Open-market buy Board of Directors bought 10,000 shares at $0.90 ($8,996)
- 4 Open-market buy Board of Directors bought 30,000 shares at $0.89 ($26,601)
- 4 Open-market buy Board of Directors bought 26,460 shares at $0.90 ($23,740)
- 4 Open-market buy Board of Directors bought 14,404 shares at $0.87 ($12,596)
- 4 Open-market buy Board of Directors bought 19,136 shares at $0.87 ($16,704)
- 4 Open-market buy Board of Directors bought 11,375 shares at $0.85 ($9,662)
Page 8 of 14 · 265 filings